BLUE : Summary for bluebird bio, Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 4 mins

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
66.30+0.95 (+1.45%)
As of 11:56AM EST. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close65.35
Bid66.00 x 1000
Ask66.20 x 400
Day's Range64.70 - 66.30
52 Week Range35.37 - 79.70
Avg. Volume1,253,235
Market Cap2.69B
PE Ratio (TTM)-11.87
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • bluebird bio, Inc. – Value Analysis (NASDAQ:BLUE) : January 24, 2017
    Capital Cube2 hours ago

    bluebird bio, Inc. – Value Analysis (NASDAQ:BLUE) : January 24, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives bluebird bio, Inc. a score of 13. Our analysis is based on comparing bluebird bio, Inc. with the following peers – Celgene Corporation, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals, Inc., Acceleron Pharma Inc, Sanofi Sponsored ADR, Merck & Co., Inc., Fibrocell Science, Inc., GlycoMimetics, Inc. and Sangamo Therapeutics, ... Read more (Read more...)

  • Capital Cubeyesterday

    bluebird bio, Inc. breached its 50 day moving average in a Bearish Manner : BLUE-US : January 23, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for bluebird bio, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Benzinga13 days ago

    Vetr Crowd Upgrades Bluebird After Trump Presser

    On Wednesday, the Vetr crowd upgraded their rating for bluebird bio Inc (NASDAQ: BLUE ), from 2.5 Stars (Sell) issued two days ago, to 3.5 Stars (Buy). Crowd sentiment for the stock is generally cautious, ...